[1] |
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17): e927-927e999. DOI: 10.1161/CIR.0000000000000484.
|
[2] |
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Circulation, 2004, 110(17): 2747-2771. DOI: 10.1161/01.CIR.0000145143.19711.78.
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
邹丽霞,龚方戚. 再发川崎病20例临床分析[J]. 中国当代儿科杂志,2008, 10(5): 617-619.
|
[10] |
王珍全,金佳蕙,荣星,等. 再发川崎病17例临床分析[J]. 浙江临床医学,2014, (8): 1279-1280.
|
[11] |
Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey[J]. J Epidemiol, 2012, 22(3): 216-221. DOI: 10.2188/jea.je20110126.
|
[12] |
Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease[J]. J Pediatr, 2008, 153(1): 117-121. DOI: 10.1016/j.jpeds.2007.12.021.
|
[13] |
Kobayashi T, Fuse S, Sakamoto N, et al. A new Z Score curve of the coronary arterial internal diameter using the Lambda-Mu-Sigma method in a pediatric population[J]. J Am Soc Echocardiogr, 2016, 29(8): 794-801.e29. DOI: 10.1016/j.echo.2016.03.017.
|
[14] |
Yang HM, Du ZD, Fu PP. Clinical features of recurrent Kawasaki disease and its risk factors[J]. Eur J Pediatr, 2013, 172(12): 1641-1647. DOI: 10.1007/s00431-013-2101-9.
|
[15] |
Chahal N, Somji Z, Manlhiot C, et al. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada[J]. Pediatr Int, 2012, 54(3): 383-387. DOI: 10.1111/j.1442-200X.2012.03628.x.
|
[16] |
Kim GB, Park S, Eun LY, et al. Epidemiology and clinical features of Kawasaki disease in South Korea, 2012-2014[J]. Pediatr Infect Dis J, 2017, 36(5): 482-485. DOI: 10.1097/INF.0000000000001474.
|
[17] |
Maddox RA, Holman RC, Uehara R, et al. Recurrent Kawasaki disease: USA and Japan[J]. Pediatr Int, 2015, 57(6): 1116-1120. DOI: 10.1111/ped.12733.
|
[18] |
de La Harpe M, di Bernardo S, Hofer M, et al. Thirty years of Kawasaki disease: a single-center study at the University Hospital of Lausanne[J]. Front Pediatr, 2019, 7: 11. DOI: 10.3389/fped.2019.00011.
|
[19] |
Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey[J]. J Epidemiol, 2010, 20(4): 302-307. DOI: 10.2188/jea.je20090180.
|
[20] |
Sharma SD, Chaturvedi K, Saini A, et al. Recurrence of coronary artery lesions after complete regression in a peculiar case of Kawasaki disease[J]. Cardiol Young, 2019, 29(5): 714-716. DOI: 10.1017/S1047951119000453.
|
[21] |
|
[22] |
Uehara R, Belay ED, Maddox RA, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan[J]. Pediatr Infect Dis J, 2008, 27(2): 155-160. DOI: 10.1097/INF.0b013e31815922b5.
|
[23] |
Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan[J]. Acta Paediatr, 2001, 90(1): 40-44. DOI: 10.1080/080352501750064851.
|
[24] |
|